Big Moving Stock keep track of the biggest moving stocks in the market.
The Hot Industries
Health Care Plans 3
Housewares & Accessories 2
The Hot Sectors
Consumer Goods 8
JNJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and womens health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSONS, AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LUBRIDERM, NEUTROGENA, RoC, VENDÔME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
"A Unique Period of Time," Revisited22 Sep 2014, 8:01 amBy The Science of Hitting. Read more » » Check out Donald Yacktman Stock Picks » Download GuruFolio Report of Donald Yacktman (Updated on 09/21/2014) , Check out Yacktman Fund Stock Picks » Download GuruFolio Report of Yacktman Fund (Updated on 09/21/2014) Related Stocks: PEP , JNJ , PG ,
1 Strong Dividend Stock You Can Buy Right Now21 Sep 2014, 1:56 pmBank certificates of deposit and savings accounts pay almost nothing in interest right now. Fortunately, investors on the hunt for income don't need to gamble on the riskiest stocks out there.
Stock Market News for September 19, 2014 - Market News19 Sep 2014, 9:06 amStock Market News for September 19, 2014 - Market News
One Put, One Call Option To Know About for Johnson & Johnson15 Sep 2014, 10:17 amConsistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from the January 2017 expiration for JNJ.
Dow Analyst Moves: JNJ10 Sep 2014, 10:18 amThe latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Johnson & Johnson (JNJ) is the #20 analyst pick. Within the broader S&P 500, when components were ranked in terms of analyst favorites, JNJ claims the #296 spot.
Interesting January 2015 Stock Options for Johnson & Johnson8 Sep 2014, 10:45 amConsistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from the January 2015 expiration for JNJ.
Will This Ratings Initiation Help Johnson & Johnson (JNJ) Stock Today?5 Sep 2014, 6:59 amNEW YORK (TheStreet) --aJohnson & Johnson a was initiated with a "outperform" rating at BMO Capital Markets on Friday. The firm said it initiated coverage on the company, which is engaged in research and development, as well as the sale of a variety of health care products, as it believes Johnson & Johnson is an industry leader and can break into emerging markets. BMO set a $118 price target on ...
Will Johnson & Johnson (JNJ) Stock Be Helped By Fast Track Ebola Vaccine?4 Sep 2014, 8:28 amNEW YORK (TheStreet) -- Shares of Johnson & Johnson are slightly higher this morning after it was reported that the company will fast track the development of a new combination vaccine regimen against Ebola amid a race to combat the worst outbreak of the deadly disease on record, Bloomberg reports. J&J said it will collaborate with Denmark-based biotech company Bavarian Nordic and the National ...
Will Johnson & Johnson (JNJ) Stock Benefit From Cordis Unit Sale?29 Aug 2014, 5:58 amNEW YORK (TheStreet) -- Johnson & Johnson will seek a buyer for its Cordis unit, aabusiness that makes medical devices including stents and catheters, sources say, in the latest move by the health care company to reduce its wide ranging portfolio, the Wall Street Journal reports. The business could be worth between $1.5 billion and $2 billion, and is expected to attract interest from private ...
Why Johnson & Johnson (JNJ) Stock Is Declining Today28 Aug 2014, 1:58 pmNEW YORK (TheStreet) -- Johnson & Johnson shares are falling, down -0.3% to $102.89,aafter the company recalled certain lotsaof its jaw implants used to lengthen and stabilize lower jaw boneadefects after injuries were reported in 15acases. The FDA announced that the recall was of the most serious Class 1 category as the device can cause serious injury or death. Infants using the product have ...